Cargando…
Integration of Human Papillomavirus Genomes in Head and Neck Cancer: Is It Time to Consider a Paradigm Shift?
Human papillomaviruses (HPV) are detected in 70–80% of oropharyngeal cancers in the developed world, the incidence of which has reached epidemic proportions. The current paradigm regarding the status of the viral genome in these cancers is that there are three situations: one where the viral genome...
Autores principales: | Morgan, Iain M., DiNardo, Laurence J., Windle, Brad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5580465/ https://www.ncbi.nlm.nih.gov/pubmed/28771189 http://dx.doi.org/10.3390/v9080208 |
Ejemplares similares
-
Analysis of The Cancer Genome Atlas sequencing data reveals novel properties of the human papillomavirus 16 genome in head and neck squamous cell carcinoma
por: Nulton, Tara J., et al.
Publicado: (2017) -
An oral keratinocyte life cycle model identifies novel host genome regulation by human papillomavirus 16 relevant to HPV positive head and neck cancer
por: Evans, Michael R., et al.
Publicado: (2017) -
Correction: An oral keratinocyte life cycle model identifies novel host genome regulation by human papillomavirus 16 relevant to HPV positive head and neck cancer
por: Evans, Michael R., et al.
Publicado: (2019) -
Paradigm shift in head and neck oncology patient management
por: van Linden van den Heuvell, Chiquit, et al.
Publicado: (2017) -
Immunotherapy for Head and Neck Cancer: A Paradigm Shift From Induction Chemotherapy to Neoadjuvant Immunotherapy
por: Shibata, Hirofumi, et al.
Publicado: (2021)